VOLANE SOURCE 450

VOLANE SOURCE 450 contains Valganciclovir Tablet IP 450 mg, an antiviral prescription medicine used for the prevention and treatment of cytomegalovirus (CMV) infections in eligible patients. Valganciclovir is an oral prodrug that is converted into ganciclovir inside the body, helping inhibit the growth and spread of CMV virus.

Valganciclovir 450 mg tablets are commonly prescribed for patients who require antiviral therapy after organ transplantation or for the management of CMV infection in individuals with weakened immune systems. This medicine works by slowing viral replication, helping the immune system control infection progression.

Manufactured and marketed by Steris Healthcare Pvt. Ltd., VOLANE SOURCE 450 is produced under WHO-GMP-certified quality standards to ensure consistent product quality and safety. The product is available as an enteric-coated delayed-release tablet in a strip of 10 tablets.

VOLANE SOURCE 450 is a prescription-only medicine and should be used strictly under the supervision of a qualified healthcare professional.

What is Valganciclovir Tablet IP 450 mg?

Valganciclovir Tablet IP 450 mg is an antiviral medication prescribed for managing cytomegalovirus (CMV) infections. CMV is a virus belonging to the herpesvirus family and can cause serious complications in people with reduced immune function, including organ transplant recipients and certain immunocompromised patients.

Valganciclovir is converted into its active form, ganciclovir, after absorption in the body. The active compound works by interfering with viral DNA production, which helps prevent CMV from multiplying.

VOLANE SOURCE 450 may be prescribed for the following:

• Prevention of CMV infection after organ transplantation
• Treatment of CMV infection in specific patients
• Management of CMV-related complications under specialist supervision

The exact duration and dosage depend on the patient’s condition, kidney function, medical history, and treatment objective.

Uses of valganciclovir 450 mg tablet

Valganciclovir Tablet IP 450 mg may be prescribed for the following:

• Prevention of cytomegalovirus (CMV) disease after transplantation
• Treatment of CMV infections in immunocompromised patients
• Reduction of CMV viral activity under medical supervision
• Supporting antiviral management in high-risk patients

This medicine is not used for treating common viral infections such as cold or flu. It is specifically prescribed for CMV-related conditions where antiviral therapy is medically required.

How Does Valganciclovir 450 mg Work?

Valganciclovir works by blocking the ability of CMV to reproduce.

After taking Valganciclovir:

1. The medicine is converted into ganciclovir inside the body.
2. Ganciclovir becomes an active antiviral compound.
3. It interferes with viral DNA polymerase, an enzyme needed for CMV replication.
4. This slows down the multiplication of the virus.

By reducing viral replication, Valganciclovir helps control CMV infection and lowers the risk of complications in patients who are vulnerable to serious viral disease.

Benefits of valganciclovir 450 mg tablet

When prescribed and used correctly, VOLANE SOURCE 450 may provide the following benefits:

• Helps manage CMV infections
• Supports prevention of CMV disease after transplantation
• Reduces CMV viral replication
• Provides convenient oral antiviral therapy
• Available in a 450 mg tablet strength
• Manufactured under WHO-GMP-certified quality standards

The effectiveness of valganciclovir depends on correct dosing, treatment duration, and regular medical monitoring.

Dosage and Administration

Take VOLANE SOURCE 450 exactly as prescribed by your doctor.

General instructions include the following:

• Swallow the tablet whole with water.
• Do not crush, chew, or break the tablet unless specifically advised.
• Take the medicine with food if recommended by your healthcare provider.
• Follow the prescribed dosing schedule carefully.
• Complete the full treatment duration even if symptoms improve.

The dosage of valganciclovir may vary depending on the following:

• Type of CMV infection
• Transplant status
• Kidney function
• Overall health condition
• Other medicines being taken

Regular blood tests may be required during treatment to monitor blood cell counts and kidney function.

Possible Side Effects

Like all medicines, VOLANE SOURCE 450 may cause side effects in some patients.

Common side effects may include:

• Headache
• Nausea
• Vomiting
• Diarrhea
• Fever
• Fatigue
• Dizziness

Valganciclovir may affect blood cell production in some patients. Serious side effects may include:

• Low white blood cell count (neutropenia)
• Low platelet count (thrombocytopenia)
• Anemia
• Kidney function changes
• Severe allergic reactions

Contact your doctor immediately if you experience unusual bleeding, persistent fever, severe weakness, allergic reactions, or signs of infection.

Precautions and Warnings

Before taking VOLANE SOURCE 450, inform your doctor if you have the following:

• Kidney disease
• Low blood cell counts
• Liver problems
• History of blood disorders
• Allergies to Valganciclovir or Ganciclovir
• Pregnancy or plans to become pregnant

Valganciclovir may affect fertility and can cause harm to an unborn baby. Women who are pregnant or planning pregnancy should discuss risks and benefits with their healthcare provider.

Patients receiving this medicine may require regular monitoring of:

• Complete blood count (CBC)
• Kidney function tests
• Liver function tests

Do not adjust the dose or stop treatment without medical advice.

Drug Interactions

Inform your doctor about all medicines, supplements, and herbal products you are taking.

Possible interactions may occur with:

• Other medicines affecting bone marrow function
• Immunosuppressive medicines
• Certain antiviral medicines
• Medicines affecting kidney function
• Chemotherapy medicines

Combining Valganciclovir with certain medicines may increase the risk of side effects, particularly blood-related complications.

Storage Instructions

Store VOLANE SOURCE 450 properly:

• Keep below 30°C
• Store in a cool and dry place
• Protect from moisture and direct sunlight
• Keep tablets in the original packaging
• Keep away from children

Do not use the medicine after the expiry date mentioned on the pack.

Why choose the valganciclovir 450 mg tablet?

VOLANE SOURCE 450 contains Valganciclovir Tablet IP 450 mg, a specialized antiviral medicine used for CMV infection management under medical supervision. Manufactured and marketed by Steris Healthcare Pvt. Ltd., it follows WHO-GMP-certified manufacturing practices to ensure quality and consistency.

With its effective antiviral mechanism and convenient oral tablet formulation, VOLANE SOURCE 450 provides an important treatment option for eligible patients requiring CMV prevention or management therapy.

Frequently Asked Questions 

1. What is Valganciclovir Tablet IP 450 mg used for?

Valganciclovir Tablet IP 450 mg is used for preventing and treating cytomegalovirus (CMV) infections in patients who require antiviral therapy, including certain transplant recipients and immunocompromised individuals.

2. How does valganciclovir 450 mg tablet work?

Valganciclovir is converted into ganciclovir in the body, which blocks CMV viral DNA replication and helps control infection.

3. Is Valganciclovir 450 mg an antibiotic?

No. Valganciclovir is an antiviral medicine, not an antibiotic. It specifically works against viral infections such as CMV.

4. Can Valganciclovir 450 mg be taken without a prescription?

No. Valganciclovir is a prescription-only medicine and should only be used under the guidance of a qualified healthcare professional.

5. How should I take valganciclovir 450 mg tablet?

Take VOLANE SOURCE 450 exactly as prescribed by your doctor. Swallow the tablet whole and follow the recommended treatment schedule.

6. What monitoring is required during Valganciclovir treatment?

Doctors may recommend regular blood tests to monitor blood cell counts and kidney function during treatment.

7. Can valganciclovir 450 mg affect kidneys?

Yes, Valganciclovir dosage may need adjustment in patients with kidney problems. Your doctor will determine the appropriate dose based on kidney function.

8. What happens if I miss a dose of Valganciclovir?

Take the missed dose when you remember. If it is close to the next scheduled dose, skip the missed dose and continue your regular schedule. Do not take extra doses without medical advice.

Product Specifications

Product Details	Information
Brand Name	VOLANE SOURCE 450
Generic Name	Valganciclovir Tablet IP 450 mg
Composition	Valganciclovir 450 mg
Dosage Form	Enteric-coated Delayed-release Tablet
Pack Size	Strip of 10 Tablets
Manufactured & Marketed By	Steris Healthcare Pvt. Ltd.
Quality Standard	WHO-GMP Certified
Prescription Status	Valid Prescription Required